Physician profile
Alan Lefkowitz
NPI 1770677114
$3,140.10
in general payments reported to CMS, 2019-2025
32 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,070 · 2020: $543 · 2021: $949 · 2022: $579.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $466.84 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $439.22 | 2019-2022 | |
| Abbvie INC. | $269.40 | 2021-2022 | |
| Pfizer INC. | $190.01 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $175.58 | 2019-2022 | |
| Lilly USA, LLC | $166.65 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $128.22 | 2020-2021 | |
| Mannkind Corporation | $117.36 | 2020-2021 | |
| Coloplast Corp | $108.36 | 2020 | |
| Astellas Pharma US INC | $106.05 | 2019-2021 | |
| Glaxosmithkline, LLC. | $102.31 | 2021-2022 | |
| Amarin Pharma, INC. | $101.91 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $99.81 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $86.21 | 2019-2020 | |
| Allergan, INC. | $61.19 | 2019 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $54.60 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $53.77 | 2021-2022 | |
| Amgen INC. | $52.63 | 2019-2020 | |
| Eisai INC. | $49.88 | 2020-2021 | |
| Antares Pharma, INC. | $39.41 | 2022 | |
| Novartis Pharmaceuticals Corporation | $39.35 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $31.85 | 2019-2022 | |
| Seqirus USA INC | $29.93 | 2021-2022 | |
| Hikma Pharmaceuticals USA | $24.34 | 2020-2021 | |
| Ultragenyx Pharmaceutical INC. | $22.43 | 2019 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $20.41 | 2022 | |
| Abbott Laboratories | $18.85 | 2022 | |
| Genzyme Corporation | $18.10 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $17.04 | 2021 | |
| Almatica Pharma LLC | $16.79 | 2021 | |
| Sanofi Pasteur INC. | $16.47 | 2019 | |
| Intuity Medical INC | $15.13 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Lefkowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.